Successful Proof-of-Concept for Topical Delivery of Novel Peptide ALM201 with Potential Usefulness for Treating Neovascular Eye Disorders

Autor: Obasanmi, Gideon, Nesbit, M. Andrew, Cobice, Diego, Mackay, Logan, McGimpsey, Stuart, Wappett, Mark, Cranston, Aaron N., Moore, Tara C.B.

Publikováno v: In Ophthalmology Science June 2022 2(2)

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical development of new drug–radiotherapy combinations

Autor: Sharma, Ricky A, Plummer, Ruth, Stock, Julie K, Greenhalgh, Tessa A, Ataman, Ozlem, Kelly, Stephen, Clay, Robert, Adams, Richard A, Baird, Richard D, Billingham, Lucinda, Brown, Sarah R, Buckland, Sean, Bulbeck, Helen, Chalmers, Anthony J, Clack, Glen, Cranston, Aaron N, Damstrup, Lars, Ferraldeschi, Roberta, Forster, Martin D, Golec, Julian, Hagan, Russell M, Hall, Emma, Hanauske, Axel-R, Harrington, Kevin J, Haswell, Tom, Hawkins, Maria A, Illidge, Tim, Jones, Hazel, Kennedy, Andrew S, McDonald, Fiona, Melcher, Thorsten, O'Connor, James PB, Pollard, John R, Saunders, Mark P, Sebag-Montefiore, David, Smitt, Melanie, Staffurth, John, Stratford, Ian J, Wedge, Stephen R, NCRI CTRad Academia-Pharma Joint Working Group

Publikováno v: Stratford, I, Sharma, R, Plummer, R, K Stock, J, A Greenhalgh, T, Atamar, O, Kelly, S, Clay, R, Adams, R, D Baird, R, Billingham, L, R Brown, S, Buckland, S, Bulbeck, H, J Chalmers, A, Clack, G, N Cranston, A, Damstrup, L, Ferraldeschi, R, D Forster, M, Golec, J, M Hagan, R, Hall, E, Hanauske, A-R, Harrington, K J, Haswell, T, A Hawkins, M, Illidge, T, Jones, H, S Kennedy, A, S Kennedy, A, McDonald, F, Melcher, T, O'Connor, J, R Pollard, J, Saunders, M P, Sebag-Montefiore, D, Smitt, M, Staffurth, J N & Wedge, S R 2016, ' Clinical Development of new Drug-Radiotherapy Combinations ', Nature Reviews Clinical Oncology, vol. 13, pp. 627-642 . https://doi.org/10.1038/nrclinonc.2016.79

In countries with the best cancer outcomes, approximately 60% of patients receive radiotherapy as part of their treatment, which is one of the most cost-effective cancer treatments. Notably, around 40% of cancer cures include the use of radiotherapy,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b399e0387a3c3f3edd68863db34342
https://eprints.gla.ac.uk/168118/1/168118.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.